期刊文献+

曲美他嗪与氢氯吡格雷联合给药对急性心肌梗死患者的影响 被引量:2

下载PDF
导出
摘要 目的:研究曲美他嗪与氢氯吡格雷联合给药对急性心肌梗死患者的影响。方法:选择行择期PCI的急性心肌梗死患者80例。随机分为两组,治疗组40例和对照组40例。对照组在PCI术前给予氢氯吡格雷口服,治疗组给予曲美他嗪与氢氯吡格雷联合给药口服。结果:经过治疗后,治疗组的综合有效率明显高于对照组。同时术后24小时的CK-MB水平治疗组低于对照组,有统计学差异(P<0.05)。结论:曲美他嗪与氢氯吡格雷联合给药能够提高急性心肌梗死患者的治疗效果,同时可显著降低术后肌酸激酶同工酶水平,发挥抗心肌损伤、细胞保护作用。
作者 郭秋花
出处 《中国社区医师(医学专业)》 2012年第19期29-30,共2页
  • 相关文献

参考文献6

二级参考文献26

  • 1严红 林曙光 等.氯沙坦与依那普利联用对慢性心力衰竭患者左室功能的影响[J].中华心血管病杂志,2000,28(3):230-230.
  • 2[1]Marc Cohen,Christine Demers,Enrique P.Gurfinkel,et,al,The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Qwave Coronary Events,N Eng J Med,1997,337:447-452.
  • 3[2]Elliott M.Antman,Carolyn H.Mc Cabe,Gurfinkel,et al.Enoxaparin prevents death and cardiac ischemia events in unstable angina/non-Q-wave myocardial infarction:results of Thrombolysis In Myocardial Infarction (TIMI-1lB) trial.Circtlation.1999,100:1593-1601.
  • 4[3]J.Ph.Collet,Montalescot,Lison,et al.Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment In Patients with Unstable Angina Pectoris.Circulation.2001,103:658-663.
  • 5[4]Elliott,Antman,Marc Cohen,David Radley,et al.Assessment of the treatment of enoxaparin for unstable angina/non-Q-wave myocardial infarction:TIMI-1lB-ESSENCE meta-analysis.Circulation.1999,100:1602-1608.
  • 6Goodfriend TL,Elliott ME,Cattk J. Drug therapy: angiotensin receptors and their antagonists[J].N Engl J Med,1996,334:1649-1661.
  • 7PittB, Segal R, Mantinel F, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure[J].Lancet,1997,349:747-752.
  • 8Urata H, Kinoshita A, Misono KS, et al. Identification of a highly specific chymase as the major angiotensin Ⅱ-forming enzyme in the human heart[J].J Biol Chem,1990,265(36):22348-22357.
  • 9Husain A. The chymase-angiotensin system in humans[J].J Hypertens,1993,11(11):1155-1159.
  • 10Urata H, Hoffmann S, Ganten D.Tissue angiotensin Ⅱsystem in the human heart[J].Eur Heart J,1994,15(suppl D):68-78.

共引文献53

同被引文献25

  • 1王远鹤,齐国先.急性心肌梗死的择期介入治疗[J].国外医学(心血管疾病分册),2005,32(3):149-151. 被引量:2
  • 2刘莉,李占全,张明,袁龙,金元哲.药物洗脱支架用于急性心肌梗死的临床观察[J].生物医学工程与临床,2005,9(6):331-333. 被引量:2
  • 3中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2012简本)[J].中华危重症医学杂志,2012,5(3):18-26.
  • 4Yang J, Kandzari DE, Gao Z, et al. Transradial versus transfemoralmethod of percutaneous coronary revasculariza- tion fofuuprotected left main coronary artery diseae:comppa- rison of procedural and late - term outcomes [ J ], JA ( X : Car- diovasc Inter,2010,3 : 1035 - 1042.
  • 5Cantor WJ. Fitchett D. Borgundvaag B, et al. Routine early angioplasty after fibrindysis for acute myocardial infarction TRANSFER - AMI Trial Investigators [ J ]. N Engl J Med, 2009,360:2705 - 2718.
  • 6Chamnarnphol N;Wisaratapong T Correlation between per- cutaneous coronary intervention volume, door - to - balloon time and mortality of patients with acute ST - segment ele- vation myocardial infarction [ J ]. J Mcd Assoc Thai, 2012, 95(3) :325.
  • 7Terkelsen C J, Sorensen JT. System delay and mortality a- mong patients with STEMI treated with primary percutancous coronary entervention[ J]. J AMA,2010,304(7):763.
  • 8Hiele H, Wohrle J, Neuhaus P, et al. Intracoronary com- pared with intravenous bolus abciximab application during primary percutaneous coronary intervention:design and ra- tionale of the Abciximab Intraeoronary Venus Intravenously Drug Application in ST- Elevation Myocardial Infarction (AIDA STEMI) trial [ J]. Am Heart J, 2010,159:547 - 554,.
  • 9Heestermans AA, Van Werkum JW, Harem C, Dill T, Gos- selink AT, De Boer M J, Van Houwelingen G, Hoorntje IC, Koopmans PC, Ten Berg JM, Van t Hof AW. Marked reduc- tion of early stent thrombosis with pre - hospital initiation of high - dose Tirofiban in ST - segment e|evation myocar- dial infarction[J]. J Thromb Haemost. 2009,7(10) : 1612 - 1628.
  • 10孙磊、黄春艳.冠心病介入治疗新进展研究[J].医药前沿,2013(1):18.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部